Uncovering a Predictive Molecular Signature for the Onset of NASH-Related Fibrosis in a Translational NASH Mouse Model

被引:52
作者
van Koppen, Arianne [1 ,2 ]
Verschuren, Lars [3 ]
van den Hoek, Anita M. [1 ]
Verheij, Joanne [4 ]
Morrison, Martine C. [1 ]
Li, Kelvin [5 ]
Nagabukuro, Hiroshi [6 ]
Costessi, Adalberto [7 ]
Caspers, Martien P. M. [3 ]
van den Broek, Tim J. [3 ]
Sagartz, John [8 ]
Kluft, Cornelis [9 ]
Beysen, Carine [5 ]
Emson, Claire [5 ]
van Gool, Alain J. [3 ,10 ]
Goldschmeding, Roel [2 ]
Stoop, Reinout [1 ]
Bobeldijk-Pastorova, Ivana [1 ]
Turner, Scott M. [5 ]
Hanauer, Guido [6 ]
Hanemaaijer, Roeland [1 ]
机构
[1] TNO, Dept Metab Hlth Res, Zernikedreef 9, NL-2333 CK Leiden, Netherlands
[2] Univ Med Ctr Utrecht, Utrecht, Netherlands
[3] TNO, Dept Microbiol & Syst Biol, Zeist, Netherlands
[4] Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands
[5] Kinemed Inc, Emeryville, CA USA
[6] Takeda Pharmaceut Co, Fujisawa, Kanagawa, Japan
[7] BaseClear BV, Leiden, Netherlands
[8] Seventh Wave, Maryland Hts, MO USA
[9] Good Biomarker Sci BV, Leiden, Netherlands
[10] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
来源
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY | 2018年 / 5卷 / 01期
关键词
Systems Biology; Metabolic Syndrome; Liver Disease; Diagnosis; FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; HEPATOCELLULAR-CARCINOMA; INSULIN-RESISTANCE; PLASMA; TRANSPLANTATION; CHROMATOGRAPHY; PATHOGENESIS; INFLAMMATION; OUTCOMES;
D O I
10.1016/j.jcmgh.2017.10.001
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: The incidence of nonalcoholic steatohepatitis (NASH) is increasing. The pathophysiological mechanisms of NASH and the sequence of events leading to hepatic fibrosis are incompletely understood. The aim of this study was to gain insight into the dynamics of key molecular processes involved in NASH and to rank early markers for hepatic fibrosis. METHODS: A time-course study in low-density lipoprotein-receptor knockout. Leiden mice on a high-fat diet was performed to identify the temporal dynamics of key processes contributing to NASH and fibrosis. An integrative systems biology approach was used to elucidate candidate markers linked to the active fibrosis process by combining transcriptomics, dynamic proteomics, and histopathology. The translational value of these findings were confirmed using human NASH data sets. RESULTS: High-fat-diet feeding resulted in obesity, hyperlipidemia, insulin resistance, and NASH with fibrosis in a time-dependent manner. Temporal dynamics of key molecular processes involved in the development of NASH were identified, including lipid metabolism, inflammation, oxidative stress, and fibrosis. A data-integrative approach enabled identification of the active fibrotic process preceding histopathologic detection using a novel molecular fibrosis signature. Human studies were used to identify overlap of genes and processes and to perform a network biology-based prioritization to rank top candidate markers representing the early manifestation of fibrosis. CONCLUSIONS: An early predictive molecular signature was identified that marked the active profibrotic process before histopathologic fibrosis becomes manifest. Early detection of the onset of NASH and fibrosis enables identification of novel blood-based biomarkers to stratify patients at risk, development of new therapeutics, and help shorten (pre) clinical experimental time frames.
引用
收藏
页码:83 / +
页数:26
相关论文
共 42 条
[31]   Intervention with a caspase-1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis and hepatic fibrosis in LDLR-/-.Leiden mice [J].
Morrison, M. C. ;
Mulder, P. ;
Salic, K. ;
Verheij, J. ;
Liang, W. ;
van Duyvenvoorde, W. ;
Menke, A. ;
Kooistra, T. ;
Kleemann, R. ;
Wielinga, P. Y. .
INTERNATIONAL JOURNAL OF OBESITY, 2016, 40 (09) :1416-1423
[32]   Hepatic Gene Expression Profiles Differentiate Presymptomatic Patients With Mild Versus Severe Nonalcoholic Fatty Liver Disease [J].
Moylan, Cynthia A. ;
Pang, Herbert ;
Dellinger, Andrew ;
Suzuki, Ayako ;
Garrett, Melanie E. ;
Guy, Cynthia D. ;
Murphy, Susan K. ;
Ashley-Koch, Allison E. ;
Choi, Steve S. ;
Michelotti, Gregory A. ;
Hampton, Daniel D. ;
Chen, Yuping ;
Tillmann, Hans L. ;
Hauser, Michael A. ;
Abdelmalek, Manal F. ;
Diehl, Anna Mae .
HEPATOLOGY, 2014, 59 (02) :471-482
[33]   Identification of the Consistently Altered Metabolic Targets in Human Hepatocellular Carcinoma [J].
Nwosu, Zeribe Chike ;
Megger, Dominik Andre ;
Hammad, Seddik ;
Sitek, Barbara ;
Roessler, Stephanie ;
Ebert, Matthias Philip ;
Meyer, Christoph ;
Dooley, Steven .
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2017, 4 (02) :303-+
[34]   Measurement of human plasma proteome dynamics with 2H2O and liquid chromatography tandem mass spectrometry [J].
Price, John C. ;
Holmes, William E. ;
Li, Kelvin W. ;
Floreani, Nicholas A. ;
Neese, Richard A. ;
Turner, Scott M. ;
Hellerstein, Marc K. .
ANALYTICAL BIOCHEMISTRY, 2012, 420 (01) :73-83
[35]   Nonalcoholic Fatty Liver Disease A Systematic Review [J].
Rinella, Mary E. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (22) :2263-2273
[36]   Severity of Nonalcoholic Fatty Liver Disease and Progression to Cirrhosis Are Associated With Atherogenic Lipoprotein Profile [J].
Siddiqui, Mohammad S. ;
Fuchs, Michael ;
Idowu, Michael O. ;
Luketic, Velimir A. ;
Boyett, Sherry ;
Sargeant, Carol ;
Stravitz, Richard T. ;
Puri, Puneet ;
Matherly, Scott ;
Sterling, Richard K. ;
Contos, Melissa ;
Sanyal, Arun J. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (05) :1000-U513
[37]   Genome-wide transcriptome analysis identifies novel gene signatures implicated in human chronic liver disease [J].
Smalling, Rana V. ;
Delker, Don A. ;
Zhang, Yuxia ;
Nieto, Natalia ;
Mcguiness, Michael S. ;
Liu, Shuanghu ;
Friedman, Scott L. ;
Hagedorn, Curt H. ;
Wang, Li .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2013, 305 (05) :G364-G374
[38]   Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients [J].
Teufel, Andreas ;
Itzel, Timo ;
Erhart, Wiebke ;
Brosch, Mario ;
Wang, Xiao Yu ;
Kim, Yong Ook ;
von Schoenfels, Witigo ;
Herrmann, Alexander ;
Brueckner, Stefan ;
Stickel, Felix ;
Dufour, Jean-Francois ;
Chavakis, Triantafyllos ;
Hellerbrand, Claus ;
Spang, Rainer ;
Maass, Thorsten ;
Becker, Thomas ;
Schreiber, Stefan ;
Schafmayer, Clemens ;
Schuppan, Detlef ;
Hampe, Jochen .
GASTROENTEROLOGY, 2016, 151 (03) :513-525
[39]   Gene expression profiling predicts clinical outcome of breast cancer [J].
van't Veer, LJ ;
Dai, HY ;
van de Vijver, MJ ;
He, YDD ;
Hart, AAM ;
Mao, M ;
Peterse, HL ;
van der Kooy, K ;
Marton, MJ ;
Witteveen, AT ;
Schreiber, GJ ;
Kerkhoven, RM ;
Roberts, C ;
Linsley, PS ;
Bernards, R ;
Friend, SH .
NATURE, 2002, 415 (6871) :530-536
[40]   A systems biology approach to understand the pathophysiological mechanisms of cardiac pathological hypertrophy associated with rosiglitazone [J].
Verschuren, Lars ;
Wielinga, Peter Y. ;
Kelder, Thomas ;
Radonjic, Marijana ;
Salic, Kanita ;
Kleemann, Robert ;
van Ommen, Ben ;
Kooistra, Teake .
BMC MEDICAL GENOMICS, 2014, 7